The Phosphotyrosine Interaction Domain of Shc Binds an LXNPXY Motif on the Epidermal Growth Factor Receptor

REFERENCES

• Aronheim, A., D. Engelberg, N. Li, N. Al-Alawi, J. Schlessinger, and M. Karin. 1994. Membrane targeting of the nucleotide exchange factor Sos is sufficient for activating the Ras signaling pathway. Cell 78:949–961.
   PubMed Web of Science ®Google Scholar
• Backer, J. M., M. G. Myers, Jr., S. E. Shoelson, D. J. Chin, X.-J. Sun, M. Miralpeix, P. Hu, B. Margolis, E. Y. Skolnik, J. Schlessinger, and M. F. White. 1992. Phosphatidylinositol 39-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J. 11:3469–3479.
   PubMed Web of Science ®Google Scholar
• Batzer, A. G., D. Rotin, J. M. Urena, E. Y. Skolnik, and J. Schlessinger. 1994. Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor. Mol. Cell. Biol. 14:5192–5201.
   PubMed Web of Science ®Google Scholar
• Batzer, A. G., et al. Unpublished observations.
   Google Scholar
• Bellot, F., W. Moolenaar, R. Kris, B. Mirakhur, I. Verlaan, A. Ullrich, J. Schlessinger, and S. Felder. 1990. High-affinity epidermal growth factor binding is specifically reduced by a monoclonal antibody, and appears necessary for early responses. J. Cell Biol. 110:491–502.
   PubMed Web of Science ®Google Scholar
• Blaikie, P., D. Immanuel, J. Wu, N. Li, V. Yajnik, and B. Margolis. 1994. A region in Shc distinct from the SH2 domain can bind tyrosine phosphory-lated growth factor receptors. J. Biol. Chem. 269:32031–32034.
   PubMed Web of Science ®Google Scholar
• Bork, P., and B. Margolis. 1995. A phosphotyrosine interaction domain. Cell 80:693–694.
   PubMed Web of Science ®Google Scholar
• Buday, L., and J. Downward. 1993. Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor. Cell 73:611–620.
   PubMed Web of Science ®Google Scholar
• Campbell, K. S., E. Ogris, B. Burke, W. Su, K. R. Auger, B. J. Druker, B. S. Schaffhausen, T. M. Roberts, and D. C. Pallas. 1994. Polyoma middle tumor antigen interacts with SHC protein via the NPTY (Asn-Pro-Thr-Tyr) motif in middle tumor antigen. Proc. Natl. Acad. Sci. USA 91:6344–6348.
   PubMedGoogle Scholar
• Chardin, P., J. H. Camonis, N. W. Gale, L. van Aelst, J. Schlessinger, M. H. Wigler, and D. Bar-Sagi. 1993. Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. Science 260:1338–1343.
   PubMed Web of Science ®Google Scholar
• Cohen, G. B., R. Ren, and D. Baltimore. 1995. Modular binding domains in signal transduction proteins. Cell 80:237–248.
   PubMed Web of Science ®Google Scholar
• Cutler, R. L., L. Liu, J. E. Damen, and G. Krystal. 1993. Multiple cytokines induce the tyrosine phosphorylation of Shc and its association with Grb2 in hemopoietic cells. J. Biol. Chem. 268:21463–21465.
   PubMed Web of Science ®Google Scholar
• Dikic, I., A. G. Batzer, P. Blaikie, A. Obermeier, A. Ullrich, J. Schlessinger, and B. Margolis. Shc binding to nerve growth factor receptor is mediated by the phosphotyrosine interaction domain. J. Biol. Chem., in press.
   Google Scholar
• Dilworth, S. M., C. E. Brewster, M. D. Jones, L. Lanfrancone, G. Pelicci, and P. G. Pelicci. 1994. Transformation by polyoma virus middle T-antigen involves the binding and tyrosine phosphorylation of Shc. Nature (London) 367:87–90.
   PubMed Web of Science ®Google Scholar
• Downward, J., P. Parker, and M. D. Waterfield. 1984. Autophosphorylation sites on the epidermal growth factor receptor. Nature (London) 311:483–485.
   PubMed Web of Science ®Google Scholar
• Egan, S. E., B. W. Giddings, M. W. Brooks, L. Buday, A. M. Sizeland, and R. A. Weinberg. 1993. Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature (London) 363:45–51.
   PubMed Web of Science ®Google Scholar
• Gustafson, T. A., W. He, A. Craparo, C. D. Schaub, and T. J. O'Neill. 1995. Phosphotyrosine-dependent interaction of Shc and IRS-1 with the NPEY motif of the insulin receptor via a novel (non-SH2) domain. Mol. Cell. Biol. 15:2500–2508.
   PubMed Web of Science ®Google Scholar
• Honegger, A., T. J. Dull, F. Bellot, E. Van Obberghen, D. Szapary, A. Schmidt, A. Ullrich, and J. Schlessinger. 1988. Biological activities of EGF-receptor mutants with individually altered autophosphorylation sites. EMBO J. 7:3045–3052.
   PubMedGoogle Scholar
• Kamps, M. P., and B. M. Sefton. 1988. Identification of multiple novel polypeptide substrates of the v-src, v-yes, v-fps, v-ros, and v-erb-B oncogenic tyrosine protein kinases utilizing antisera against phosphotyrosine. Oncogene 2:305–315.
   PubMedGoogle Scholar
• Kashishian, A., and J. A. Cooper. 1993. Phosphorylation sites at the C-terminus of the platelet-derived growth factor receptor bind phospholipase C gamma 1. Mol. Biol. Cell 4:49–57.
   PubMedGoogle Scholar
• Kavanaugh, W. M., and L. T. Williams. 1994. An alternative to SH2 domains for binding tyrosine-phosphorylated proteins. Science 266:1862–1865.
   PubMed Web of Science ®Google Scholar
• Kris, R. M., I. Lax, W. Gullick, M. D. Waterfield, A. Ullrich, M. Fridkin, and J. Schlessinger. 1985. Antibodies against a synthetic peptide as a probe for the kinase activity of the avian EGF receptor and v-erbB protein. Cell 40:619–625.
   PubMed Web of Science ®Google Scholar
• Labudda, K., S. Meyer, and M. Hayman. 1995. Identification of the binding site for the Shc protein to the avian erythroblastosis virus (AEV-H) v-erbB protein. Virology 206:269–275.
   PubMedGoogle Scholar
• Li, N., A. Batzer, R. Daly, V. Yajnik, E. Skolnik, P. Chardin, D. Bar-Sagi, B. Margolis, and J. Schlessinger. 1993. Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling. Nature (London) 363:85–88.
   PubMed Web of Science ®Google Scholar
• Margolis, B., S. G. Rhee, S. Felder, M. Mervic, R. Lyall, A. Levitski, A. Ullrich, A. Zilberstein, and J. Schlessinger. 1989. EGF induces tyrosine phosphorylation of phospholipase C-II: a potential mechanism for EGF receptor signaling. Cell 57:1101–1107.
   PubMed Web of Science ®Google Scholar
• Margolis, B. L., I. Lax, R. Kris, M. Dombalagian, A. M. Honegger, R. Howk, D. Givol, A. Ullrich, and J. Schlessinger. 1989. All autophosphorylation sites of epidermal growth factor (EGF) receptor and HER2/neu are located in their carboxyl-terminal tails. Identification of a novel site in EGF receptor. J. Biol. Chem. 264:10667–10671.
   Google Scholar
• Obermeier, A., R. A. Bradshaw, K. Seedorf, A. Choidas, J. Schlessinger, and A. Ullrich. 1994. Neuronal differentiation signals are controlled by nerve growth factor receptor/Trk binding sites for SHC and PLC gamma. EMBO J. 13:1585–1590.
   PubMed Web of Science ®Google Scholar
• Okabayashi, Y., Y. Kido, T. Okutani, Y. Sugimoto, K. Sakaguchi, and M. Kasuga. 1994. Tyrosines 1148 and 1173 of activated human epidermal growth factor receptors are binding sites of Shc in intact cells. J. Biol. Chem. 269:18674–18678.
   PubMed Web of Science ®Google Scholar
• Pawson, T. 1995. Protein modules and signalling networks. Nature (London) 373:573–580.
   PubMed Web of Science ®Google Scholar
• Pelicci, G., L. Lanfrancone, F. Grignani, J. McGlade, F. Cavallo, G. Forni, I. Nicoletti, T. Pawson, and P. G. Pelicci. 1992. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 70:93–104.
   PubMed Web of Science ®Google Scholar
• Pendergast, A. M., L. A. Quilliam, L. D. Cripe, C. H. Bassing, Z. Dai, N. Li, A. Batzer, K. M. Rabun, C. J. Der, J. Schlessinger, et al. 1993. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell 75:175–185.
   PubMed Web of Science ®Google Scholar
• Prigent, S. A., and W. J. Gullick. 1994. Identification of c-erbB-3 binding sites for phosphatidylinositol 39-kinase and SHC using an EGF receptor/c-erbB-3 chimera. EMBO J. 13:2831–2841.
   PubMed Web of Science ®Google Scholar
• Pronk, G. J., J. McGlade, G. Pelicci, T. Pawson, and J. L. Bos. 1993. Insulin-induced phosphorylation of the 46- and 52-kDa Shc proteins. J. Biol. Chem. 268:5748–5753.
   PubMed Web of Science ®Google Scholar
• Quilliam, L. A., S. Y. Huff, K. M. Rabun, W. Wei, W. Park, D. Broek, and C. J. Der. 1994. Membrane-targeting potentiates guanine nucleotide exchange factor CDC25 and SOS1 activation of Ras transforming activity. Proc. Natl. Acad. Sci. USA 91:8512–8516.
   PubMed Web of Science ®Google Scholar
• Rotin, D., B. Margolis, M. Mohammadi, R. J. Daly, G. Daum, N. Li, E. H. Fischer, W. H. Burgess, A. Ullrich, and J. Schlessinger. 1992. SH2 domains prevent tyrosine dephosphorylation of the EGF receptor: identification of Tyr992 as the high-affinity binding site for SH2 domains of phospholipase C gamma. EMBO J. 11:559–567.
   PubMedGoogle Scholar
• Rozakis-Adcock, M., R. Fernley, J. Wade, T. Pawson, and D. Bowtell. 1993. The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1. Nature (London) 363:83–85.
   PubMed Web of Science ®Google Scholar
• Salcini, A. E., J. McGlade, G. Pelicci, I. Nicoletti, T. Pawson, and P. G. Pelicci. 1994. Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins. Oncogene 9:2827–2836.
   PubMedGoogle Scholar
• Schlessinger, J. 1994. SH2/SH3 signaling proteins. Curr. Opin. Genet. Dev. 4:25–30.
   PubMedGoogle Scholar
• Segatto, O., G. Pelicci, S. Giuli, G. Digiesi, P. P. Di Fiore, J. McGlade, T. Pawson, and P. G. Pelicci. 1993. Shc products are substrates of erbB-2 kinase. Oncogene 8:2105–2112.
   PubMedGoogle Scholar
• Skolnik, E. Y., C. H. Lee, A. Batzer, L. M. Vicentini, M. Zhou, R. Daly, M. J. Myers, Jr., J. M. Backer, A. Ullrich, M. F. White, and J. Schlessinger. 1993. The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signalling. EMBO J. 12:1929–1936.
   PubMed Web of Science ®Google Scholar
• Soler, C., L. Beguinot, and G. Carpenter. 1994. Individual epidermal growth factor receptor autophosphorylation sites do not stringently define association motifs for several SH2-containing proteins. J. Biol. Chem. 269:12320–12324.
   PubMedGoogle Scholar
• Stein, D., J. Wu, S. A. W. Fuqua, C. Roonprapunt, V. Yajnik, P. D'Eustachio, J. J. Moskow, A. M. Buchberg, C. K. Osborne, and B. Margolis. 1994. The SH2 domain protein GRB-7 is coamplified, overexpressed and in a tight complex with HER2 in breast cancer. EMBO J. 13:1331–1340.
   PubMed Web of Science ®Google Scholar
• Stephens, R. M., D. M. Loeb, T. D. Copeland, T. Pawson, L. A. Greene, and D. R. Kaplan. 1994. Trk receptors use redundant signal transduction pathways involving SHC and PLC-gamma 1 to mediate NGF responses. Neuron 12:691–705.
   PubMed Web of Science ®Google Scholar
• Valius, M., C. Bazenet, and A. Kazlauskas. 1993. Tyrosines 1021 and 1009 are phosphorylation sites in the carboxy terminus of the platelet-derived growth factor receptor β subunit and are required for binding of phospho-lipase Cγ and a 64-kilodalton protein, respectively. Mol. Cell. Biol. 13:133–143.
   PubMedGoogle Scholar
• Walton, G. M., W. S. Chen, M. G. Rosenfeld, and G. N. Gill. 1990. Analysis of deletions of the carboxyl terminus of the epidermal growth factor receptor reveals self-phosphorylation at tyrosine 992 and enhanced in vivo tyrosine phosphorylation of cell substrates. J. Biol. Chem. 265:1750–1754.
   PubMedGoogle Scholar